Dementia and delirium

On this page

Quick Overview

Dementia and delirium represent distinct but clinically overlapping cognitive syndromes requiring urgent differentiation. Delirium is an acute, fluctuating confusional state (medical emergency), while dementia is a chronic, progressive decline. The 4AT score enables rapid bedside differentiation, and NICE NG97 provides structured guidance on investigation, diagnosis, and pharmacological management of dementia subtypes.

Core Facts & Concepts

Delirium vs Dementia Key Features:

FeatureDeliriumDementia
OnsetHours-days (acute)Months-years (insidious)
CourseFluctuating (worse at night)Progressive, stable daily
AttentionSeverely impairedPreserved until late
ConsciousnessAltered/cloudedAlert until advanced
ReversibilityOften reversibleIrreversible (mostly)

4AT Score (Delirium Screening):

  • 0 = Delirium unlikely
  • 1-3 = Possible cognitive impairment
  • ≥4 = Probable delirium
  • Components: Alertness (0-4), AMT4 (0-2), Attention (0-2), Acute change (0-4)

Figure 1: CT brain showing generalised cerebral atrophy with enlarged ventricles and widened sulci

Reversible Causes of Dementia (Screen All):

  • Vitamin B12/folate deficiency (<200 ng/L)
  • Hypothyroidism (TSH >10 mU/L)
  • Hypercalcaemia (>2.6 mmol/L)
  • Normal pressure hydrocephalus (triad: dementia, gait apraxia, incontinence)
  • Chronic subdural haematoma
  • Depression ("pseudodementia")

Cognitive Assessment Tools:

  • ACE-III: 100-point scale (≥88 = normal, <82 = impaired)
  • MoCA: 30-point scale (≥26 = normal, sensitive to mild cognitive impairment)
  • MMSE: 30-point scale (outdated, copyright issues)

Problem-Solving Approach

Step 1: Exclude Delirium First

  1. Apply 4AT score at bedside (takes 2 minutes)
  2. If ≥4: Investigate for underlying cause (sepsis, drugs, metabolic, hypoxia)
  3. Manage delirium before assessing for dementia

Step 2: Confirm Dementia Diagnosis

  1. Cognitive impairment affecting ≥2 domains (memory, language, executive, visuospatial)
  2. Functional decline in ADLs
  3. Duration >6 months
  4. Not explained by delirium/psychiatric disorder

Figure 2: MRI brain T2 showing bilateral hippocampal atrophy in Alzheimer's disease

Step 3: Investigate Reversible Causes (NICE NG97)

  • Bloods: FBC, U&E, LFTs, calcium, glucose, TSH, B12/folate
  • Neuroimaging: MRI brain (or CT if contraindicated)
  • Consider: HIV, syphilis serology if risk factors

Step 4: Subtype Classification

  • Alzheimer's (60%): Gradual memory loss, temporal/hippocampal atrophy
  • Vascular (20%): Stepwise decline, stroke history, white matter changes
  • Lewy body (15%): Visual hallucinations, parkinsonism, fluctuating cognition
  • Frontotemporal (5%): Personality change, disinhibition, frontal atrophy

🚩 Red Flags: Age <60, rapid progression (<2 years), focal neurology, headache, seizures → refer neurology urgently

Analysis Framework

Acetylcholinesterase Inhibitors (NICE NG97 Criteria):

DrugDementia TypeInitiation CriteriaMMSE Range
DonepezilAlzheimer's, Lewy bodyMild-moderate10-26
RivastigmineAlzheimer's, Lewy body, Parkinson'sMild-moderate10-26
GalantamineAlzheimer's onlyMild-moderate10-26
MemantineModerate-severe Alzheimer'sMMSE <10 OR intolerant to above<20

When to Start Treatment (All Required):

  1. Confirmed Alzheimer's/Lewy body dementia diagnosis
  2. MMSE 10-26 (mild-moderate)
  3. Specialist (memory clinic) initiation
  4. Review at 3 months (continue if MMSE stable/improved AND functional benefit)

⚠️ Warning: Do NOT use antipsychotics routinely in dementia (↑ stroke risk, ↑ mortality). Reserve for severe distress/risk only.

Visual Aid

Delirium Precipitants Mnemonic:

📌 Remember: PINCH ME - Pain, Infection, Nutrition, Constipation, Hydration, Medication, Environment

Key Points Summary

4AT score ≥4 = probable delirium (medical emergency requiring urgent investigation)

Dementia diagnosis requires: ≥2 cognitive domains affected + functional decline + >6 months duration

Always screen reversible causes: B12, folate, TSH, calcium + MRI brain (NICE NG97 mandatory)

Acetylcholinesterase inhibitors (donepezil/rivastigmine/galantamine): Start if Alzheimer's/Lewy body + MMSE 10-26 + specialist initiation

Memantine: Reserved for moderate-severe Alzheimer's (MMSE <20) or intolerance to cholinesterase inhibitors

Avoid antipsychotics in dementia unless severe distress/risk (↑ stroke, ↑ mortality)

ACE-III >88 = normal, <82 = cognitive impairment (more sensitive than MMSE for mild cases)

Practice Questions: Dementia and delirium

Test your understanding with these related questions

A 49-year-old man presents with progressive weakness in his arms and legs over 24 months. He has bulbar symptoms including dysphagia and dysarthria. EMG shows widespread denervation. What is the most important prognostic factor?

1 of 5

Flashcards: Dementia and delirium

1/10

What condition would anticholinergic medication be contraindicated for urgency incontinence _____

TAP TO REVEAL ANSWER

What condition would anticholinergic medication be contraindicated for urgency incontinence _____

Myasthenia Gravis

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial